• The Daily Trade
  • Posts
  • LIV Golf's New CEO Scott O'Neil Promises a Game-Changer for the League!

LIV Golf's New CEO Scott O'Neil Promises a Game-Changer for the League!

Recent Headlines

LIV Golf's New Vision: Scott O'Neil Takes the Helm as CEO
LIV Golf is shaking things up with Scott O'Neil stepping in as CEO, promising to energize the league as it gears up for its fourth season. With ongoing negotiations with the PGA Tour, O'Neil's leadership could be the catalyst for a new era in golf. Can LIV Golf score big under his guidance?
AstraZeneca is in hot water as its stock tumbles 15% over allegations of illegal drug imports and insurance fraud in China. Investors are now eyeing a class action lawsuit, questioning the company's transparency. With a critical market at stake, the pressure is on for AstraZeneca to navigate these choppy waters!
Regeneron Pharmaceuticals is under scrutiny after a disappointing earnings report triggered a $9 billion drop in market value. The company is now facing a securities class action lawsuit over alleged misleading sales practices related to its EYLEA product. Investors are understandably concerned—can Regeneron bounce back from this setback?
Celsius Holdings is feeling the heat as its stock faces a class action lawsuit linked to inventory issues with PepsiCo. With sales predictions taking a dive, investors are left wondering if this energy drink maker can regain its fizz. The stakes are high, and the pressure is mounting!
Boston Beer is raising eyebrows as Citigroup slashes its price target to $290. With analysts expressing caution, the iconic beverage company is navigating a challenging market landscape. Will Boston Beer find a way to brew up some positive momentum?
Rocket Lab USA's stock took an 8.7% dive, but analysts are still singing its praises with multiple 'buy' ratings and increased price targets. As the company continues to innovate in the aerospace sector, investors are left to wonder—will Rocket Lab soar back to new heights?


Technical Analysis Results



Overvalued
BBIO
BridgeBio Pharma, Inc. Common Stock
Volume: 4.1M shares | Price: $35.00

30 Day Performance
30-Day Price History

Technical Indicator Score: 100% Sell
Out of the 8 technical indicators that were used to analyze this stock, 8 indicated sell signals.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Sell
ULTOSC
Sell
STOCH
Sell

Recent Mentions of BBIO






Undervalued
STZ
Constellation Brands, Inc.
Volume: 2.9M shares | Price: $180.72

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Hold
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Buy

Recent Mentions of STZ






Undervalued
KROS
Keros Therapeutics, Inc. Common Stock
Volume: 13.6M shares | Price: $10.42

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Hold

Recent Mentions of KROS






Undervalued
LVS
Las Vegas Sands Corp.
Volume: 5.5M shares | Price: $44.20

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Hold

Recent Mentions of LVS






Undervalued
QSR
Restaurant Brands International Inc.
Volume: 1.4M shares | Price: $60.44

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of QSR






Undervalued
BF.B
Brown-Forman Corporation Class B
Volume: 2.4M shares | Price: $33.69

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of BF.B




Check out our partners!

We’ve teamed up with a few like-minded newsletters to bring you even more fresh insights and fun. If you’re craving extra knowledge, entertainment, and/or inspiration in your inbox, give them a look below!

1. Pour Decisions - Your sommelier-approved excuse to open another bottle. Get weekly wine recommendations from top sommeliers across the world.

2. Labrador - Discover high-return real estate deals daily with Labrador— the ultimate bird dog for smart investors.

3. Quip - A daily dose of jokes, trivia, and inspiration to brighten your day.

We want to hear from YOU!

Technical indicator analysis feedback request

Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.

Simply reply to this email with your thoughts. Every comment helps us serve you better.

Thank you for being a valued reader.

How would you rate today's newsletter?

If there's anything I can do better, please let me know so I can make improvements!

Login or Subscribe to participate in polls.

Let’s stay in touch!

Thank you for reading today’s edition of The Daily Trade.

Let’s connect on LinkedIn!

-Ryan Serkes

Subscribe here if this email was forwarded to you!

Technical Indicator Information

Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30

Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20

Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80

Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75

Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal

Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20

Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100

Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band

Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price

Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0

Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30

Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI

Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25

Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.

Disclaimers

The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.

Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.

The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.